Fresenius Medical Care AG & Co. KGaA  / Key word(s): Final Results/Forecast

25.02.2015 07:00

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Fresenius Medical Care has achieved its targets for the fiscal year 2014.

Net revenue of Fresenius Medical Care AG & Co. KGaA increased by 8% to
$15,832 million as compared to the full year 2013.

Operating income (EBIT) for the full year 2014 remained nearly flat at
$2,255 million.

Net income attributable to shareholders of Fresenius Medical Care AG & Co.
KGaA decreased by 6% to $1,045 million.

For the 18th consecutive year shareholders can expect to receive an
increased annual dividend. At the ordinary annual general meeting to be
held on May 19, 2015, shareholders will be asked to approve a dividend per
share of EUR0.78, an increase of 1% (2013: EUR0.77).

The information provided is based on exchange rates prevailing at the
beginning of 2015. Savings from the global efficiency program are included,
while potential acquisitions are not. In addition the outlook reflects
further operating cost investments within the Care Coordination segment for
future growth in line with our 2020 strategy.

For the full year 2015, Fresenius Medical Care expects revenue to grow at 
5-7%, which at constant currency is a growth rate of 10-12%. Net income
attributable to shareholders of Fresenius Medical Care AG & Co. KGaA is
expected to increase 0-5%.

For the year 2016 we expect an acceleration of growth with a revenue
increase of 9-12% and net income attributable to shareholders of Fresenius
Medical Care AG & Co. KGaA growing by 15-20%.

As disclosed in the company's long-term target for 2020 the company expects
revenue to grow at an average annual growth rate of approx. 10% and net
income attributable to shareholders in the high single digits.

Fresenius SE & Co. KGaA holds approximately 30.3% of Fresenius Medical Care
AG & Co. KGaA's capital.

Fresenius Medical Care AG & Co. KGaA
Represented by Fresenius Medical Care Management AG 
Represented by its management board 
Bad Homburg v.d.H., February 25, 2015


25.02.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Fresenius Medical Care AG & Co. KGaA
              Else-Kröner-Straße 1
              61352 Bad Homburg
              Germany
Phone:        +49 (0) 6172- 609 2525
Fax:          +49 (0) 6172- 609 2301
E-mail:       ir@fmc-ag.com
Internet:     www.fmc-ag.de
ISIN:         DE0005785802, DE0005785836, 
WKN:          578580, 578583
Indices:      DAX
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated
              Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,
              Munich, Stuttgart; Terminbörse EUREX; NYSE
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------